Pinsent Masons advises the UK government on purchase of further 60m doses of Covid-19 vaccines

10 May 2021 | 09:36 am |

Multinational law firm Pinsent Masons has successfully advised the UK government on an agreement to purchase an additional 60m doses of the Pfizer BioNTech Covid-19 vaccine for the autumn revaccination programme.

The team at Pinsent Masons was led by Life Sciences transactions partner Allistair Booth and included Andy Cornforth, Niki Ruprai, Robert Sherville-Payne and Aaron Hope. 

Commenting on the agreement, Allistair Booth, lead partner at Pinsent Masons said:

"This is an important agreement. Access to 60m doses of that vaccine in time for an autumn revaccination programme will hopefully play a key role in protecting the NHS and the most vulnerable people of the UK.


"We are proud to have worked with the UK government on securing this agreement for such an important vaccine at such a crucial time".  

Latest press releases

Show me all press releases

Pinsent Masons commits to London Data Charter to tackle London’s biggest challenges

Multinational law firm Pinsent Masons has created, and committed to, the London Data Charter - a statement of intent that organisations, both public and private, can adopt to put data at the heart of solving London’s biggest challenges.

Pinsent Masons bolsters Climate Change Mitigation and Sustainability team

Multinational law firm Pinsent Masons has named Michael Watson as its new Head of Climate Change Mitigation and Sustainability team, and appointed former OFGEM General Counsel, Euan McVicar, as Senior Climate Adviser.

Pinsent Masons appoints leading Life Sciences IP partner in London

Multinational law firm Pinsent Masons has recruited Life Sciences partner Gina Bicknell, adding additional skills and strength to its Technology, Science and Industry (TSI) sector capabilities.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons appoints leading Life Sciences IP partner in London

Multinational law firm Pinsent Masons has recruited Life Sciences partner Gina Bicknell, adding additional skills and strength to its Technology, Science and Industry (TSI) sector capabilities.

Pinsent Masons Advises NEXA Enterprise Asset Management on Acquisition By Transcat Inc

Multinational law firm Pinsent Masons has advised NEXA on its acquisition by Transcat Inc.

Pinsent Masons collaborates with LifeArc on expert paper to support drug repurposing

Multinational law firm Pinsent Masons has collaborated with medical research charity LifeArc, on a new report offering expert advice, insights and practical tips to charities, researchers and funders hoping to repurpose drugs for other – often rare and fatal – conditions.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts